18 Aug 2017
Food Facility and Importer Re-inspection Fees Set for FY 2018
The Food and Drug Administration has announced its fiscal year 2018 fee rates for certain domestic and foreign food facility re-inspections, failures to comply with a recall order and importer re-inspections. Fees for these services will be assessed at US$248 per hour if domestic travel is required (up from US$221 in FY 2017) and US$285 per hour if foreign travel is required (unchanged from FY 2017). These fees will be effective as of 1 October 2017 and remain in effect through 30 September 2018.
It is possible, however, that the fees will not actually be assessed during all or part of this period. This is because the FDA (i) does not intend to issue invoices for re-inspection or recall order fees until it publishes a guidance document on how small businesses may request a reduction of those fees given the “severe economic hardship” that paying them could cause, and (ii) is still considering various issues associated with the assessment and collection of importer re-inspection fees.
Under the Food Safety Modernization Act the FDA may assess a fee for a re-inspection that is (i) conducted to determine whether corrective actions have been implemented and are effective and compliance has been achieved to the FDA’s satisfaction at a facility that manufactures, processes, packs or holds food for consumption and (ii) necessitated as a result of a previous inspection of the facility that had a final classification of “official action indicated” when the FDA determined that the non-compliance was materially related to food safety requirements of the Federal Food, Drug, and Cosmetic Act. This fee may be collected from the responsible party for each domestic facility and the U.S. agent for each foreign facility subject to a re-inspection.
The FDA is also authorised to assess fees for not complying with a recall order; e.g., not initiating a recall as ordered by the FDA, not conducting a recall in the manner specified by the FDA in a recall order, or not providing the FDA with requested information regarding an FDA-ordered recall. Such fees are to be paid by the responsible party for a domestic facility and an importer who does not comply with a recall order.